ENTA ENANTA PHARMACEUTICALS INC
Nasdaq · SEC CIK 1177648 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $183.2K 9 sales by 7 insiders
- Filings on record
- 177 since 2021-08-23, latest 2026-08-10 09:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Luly Jay R. | Pres, CEO, Dir | — | $67.5K |
| Or Yat Sun | CSO | — | $34.0K |
| Kieffer Tara Lynn | Chief Product Strategy Off | — | $30.0K |
| Luu Brendan | Chief Business Off | — | $19.8K |
| Trout Harry R. III | See Remarks | — | $13.0K |
| Rottinghaus Scott T. | Chief Medical Off | — | $11.4K |
| Capps Kathleen S. | See Remarks | — | $7,486 |
| Kowalsky Matthew Paul | CLO | — | — |
Transactions 173
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 09:00 | 2026-08-08 | ENTA | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $13.34 | -1,467 | 23.8K | -6% | -$19.6K | |
| M | 2026-02-13 | 2026-02-12 | ENTA | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +6,875 | 23.4K | +41% | $0 |
| 2026-02-13 | 2026-02-12 | ENTA | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $14.25 | -3,413 | 25.3K | -12% | -$48.6K | |
| 2026-02-13 | 2026-02-12 | ENTA | Luu Brendan | Chief Business Off | F - Tax | $14.25 | -3,257 | 41.6K | -7% | -$46.4K | |
| M | 2026-02-13 | 2026-02-12 | ENTA | Luu Brendan | Chief Business Off | A - Grant | $0.00 | +6,562 | 44.9K | +17% | $0 |
| M | 2026-02-13 | 2026-02-12 | ENTA | Kowalsky Matthew Paul | CLO | A - Grant | $0.00 | +5,493 | 1,318 | New | $0 |
| 2026-02-13 | 2026-02-12 | ENTA | Kowalsky Matthew Paul | CLO | F - Tax | $14.25 | -1,902 | 3,591 | -35% | -$27.1K | |
| 2026-02-13 | 2026-02-12 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | F - Tax | $14.25 | -3,257 | 33.9K | -9% | -$46.4K | |
| M | 2026-02-13 | 2026-02-12 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | A - Grant | $0.00 | +6,562 | 32.2K | +26% | $0 |
| M | 2026-02-13 | 2026-02-12 | ENTA | Luly Jay R. | Pres, CEO, Dir | A - Grant | $0.00 | +20.0K | 878.0K | +2% | $0 |
| 2026-02-13 | 2026-02-12 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $14.25 | -6,155 | 871.9K | -0.7% | -$87.7K | |
| M | 2026-02-13 | 2026-02-12 | ENTA | Or Yat Sun | CSO | A - Grant | $0.00 | +6,875 | 373.0K | +2% | $0 |
| 2026-02-13 | 2026-02-12 | ENTA | Or Yat Sun | CSO | F - Tax | $14.25 | -3,413 | 374.9K | -0.9% | -$48.6K | |
| 2025-12-05 | 2025-12-05 | ENTA | Capps Kathleen S. | See Remarks | S - Sale | $14.23 | -323 | 8,377 | -4% | -$4,596 | |
| 2025-12-05 | 2025-12-05 | ENTA | Or Yat Sun | CSO | S - Sale | $14.23 | -2,390 | 371.4K | -0.6% | -$34.0K | |
| 2025-12-05 | 2025-12-05 | ENTA | Rottinghaus Scott T. | Chief Medical Off | S - Sale | $14.23 | -798 | 21.8K | -4% | -$11.4K | |
| 2025-12-05 | 2025-12-05 | ENTA | Luu Brendan | Chief Business Off | S - Sale | $14.23 | -1,394 | 38.3K | -4% | -$19.8K | |
| 2025-12-05 | 2025-12-05 | ENTA | Luly Jay R. | Pres, CEO, Dir | S - Sale | $14.23 | -4,743 | 858.0K | -0.5% | -$67.5K | |
| 2025-12-05 | 2025-12-05 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | S - Sale | $14.23 | -2,106 | 30.6K | -6% | -$30.0K | |
| 2025-12-05 | 2025-12-05 | ENTA | Trout Harry R. III | See Remarks | S - Sale | $14.23 | -542 | 16.3K | -3% | -$7,713 | |
| 2025-12-03 | 2025-12-02 | ENTA | Trout Harry R. III | See Remarks | S - Sale | $13.96 | -380 | 16.9K | -2% | -$5,305 | |
| 2025-12-03 | 2025-12-01 | ENTA | Trout Harry R. III | See Remarks | F - Tax | $14.12 | -105 | 17.3K | -0.6% | -$1,483 | |
| 2025-12-03 | 2025-12-01 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | F - Tax | $14.12 | -753 | 32.7K | -2% | -$10.6K | |
| 2025-12-03 | 2025-12-01 | ENTA | Or Yat Sun | CSO | F - Tax | $14.12 | -753 | 373.8K | -0.2% | -$10.6K | |
| 2025-12-03 | 2025-12-01 | ENTA | Luu Brendan | Chief Business Off | F - Tax | $14.12 | -498 | 39.7K | -1% | -$7,032 | |
| 2025-12-03 | 2025-12-02 | ENTA | Capps Kathleen S. | See Remarks | S - Sale | $13.96 | -207 | 8,700 | -2% | -$2,890 | |
| 2025-12-03 | 2025-12-01 | ENTA | Capps Kathleen S. | See Remarks | F - Tax | $14.12 | -85 | 8,907 | -0.9% | -$1,200 | |
| 2025-12-03 | 2025-12-01 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $14.12 | -1,885 | 862.8K | -0.2% | -$26.6K | |
| D | 2025-11-26 | 2025-11-25 | ENTA | Trout Harry R. III | See Remarks | A - Grant | $0.00 | +6,463 | 17.4K | +59% | $0 |
| D | 2025-11-26 | 2025-11-25 | ENTA | Capps Kathleen S. | See Remarks | A - Grant | $0.00 | +3,163 | 8,992 | +54% | $0 |
| 2025-08-08 | 2025-08-08 | ENTA | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $6.99 | -2,217 | 22.6K | -9% | -$15.5K | |
| 2025-02-14 | 2025-02-12 | ENTA | Or Yat Sun | CSO | F - Tax | $5.59 | -4,324 | 374.5K | -1% | -$24.2K | |
| 2025-02-14 | 2025-02-12 | ENTA | Or Yat Sun | CSO | A - Grant | $0.00 | +9,750 | 378.9K | +3% | $0 | |
| 2025-02-14 | 2025-02-12 | ENTA | MELLETT PAUL J | Chief Fin, Admin Off | F - Tax | $5.59 | -3,326 | 95.9K | -3% | -$18.6K | |
| 2025-02-14 | 2025-02-12 | ENTA | MELLETT PAUL J | Chief Fin, Admin Off | A - Grant | $0.00 | +7,500 | 99.2K | +8% | $0 | |
| 2025-02-14 | 2025-02-12 | ENTA | Luu Brendan | Chief Business Off | A - Grant | $0.00 | +7,500 | 43.5K | +21% | $0 | |
| 2025-02-14 | 2025-02-12 | ENTA | Luu Brendan | Chief Business Off | F - Tax | $5.59 | -3,326 | 40.2K | -8% | -$18.6K | |
| 2025-02-14 | 2025-02-12 | ENTA | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +9,750 | 27.7K | +54% | $0 | |
| 2025-02-14 | 2025-02-12 | ENTA | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $5.59 | -2,861 | 24.8K | -10% | -$16.0K | |
| 2025-02-14 | 2025-02-12 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | A - Grant | $0.00 | +7,500 | 36.8K | +26% | $0 | |
| 2025-02-14 | 2025-02-12 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | F - Tax | $5.59 | -3,326 | 33.5K | -9% | -$18.6K | |
| 2025-02-14 | 2025-02-12 | ENTA | Luly Jay R. | Pres, CEO, Dir | A - Grant | $0.00 | +25.5K | 872.1K | +3% | $0 | |
| 2025-02-14 | 2025-02-12 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $5.59 | -7,484 | 864.7K | -0.9% | -$41.8K | |
| 2025-02-12 | 2025-02-12 | ENTA | Luly Jay R. | Pres, CEO, Dir | P - Purchase | $5.69 | +45.0K | 846.6K | +6% | +$256.1K | |
| 2024-12-10 | 2024-12-06 | ENTA | Luu Brendan | Chief Business Off | S - Sale | $8.06 | -2,283 | 36.0K | -6% | -$18.4K | |
| 2024-12-10 | 2024-12-06 | ENTA | Rottinghaus Scott T. | Chief Medical Off | S - Sale | $8.06 | -866 | 17.9K | -5% | -$6,980 | |
| 2024-12-10 | 2024-12-06 | ENTA | Or Yat Sun | CSO | S - Sale | $8.06 | -2,591 | 369.1K | -0.7% | -$20.9K | |
| 2024-12-10 | 2024-12-06 | ENTA | MELLETT PAUL J | Chief Fin, Admin Off | S - Sale | $8.06 | -2,591 | 91.7K | -3% | -$20.9K | |
| 2024-12-10 | 2024-12-06 | ENTA | Luly Jay R. | Pres, CEO, Dir | S - Sale | $8.06 | -5,142 | 801.6K | -0.6% | -$41.4K | |
| 2024-12-10 | 2024-12-06 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | S - Sale | $8.06 | -2,283 | 29.3K | -7% | -$18.4K | |
| 2024-12-03 | 2024-12-01 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | F - Tax | $8.60 | -753 | 31.6K | -2% | -$6,476 | |
| 2024-12-03 | 2024-12-01 | ENTA | MELLETT PAUL J | Chief Fin, Admin Off | F - Tax | $8.60 | -1,595 | 94.3K | -2% | -$13.7K | |
| 2024-12-03 | 2024-12-01 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $8.60 | -3,829 | 806.8K | -0.5% | -$32.9K | |
| 2024-12-03 | 2024-12-01 | ENTA | Or Yat Sun | CSO | F - Tax | $8.60 | -1,595 | 371.7K | -0.4% | -$13.7K | |
| 2024-12-03 | 2024-12-01 | ENTA | Luu Brendan | Chief Business Off | F - Tax | $8.60 | -753 | 38.3K | -2% | -$6,476 | |
| M | 2024-08-09 | 2023-08-08+ | ENTA | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $14.98 | -2,933 | 18.8K | -14% | -$43.9K |
| DM | 2024-07-15 | 2024-07-11+ | ENTA | Rottinghaus Scott T. | Chief Medical Off | S - Sale+OE | $15.97 | -11.9K | 21.7K | -35% | -$190.7K |
| D | 2024-07-15 | 2024-07-15 | ENTA | Rottinghaus Scott T. | Chief Medical Off | M - OptEx | $8.99 | +5,375 | 27.1K | +25% | +$48.3K |
| 2024-06-17 | 2024-06-17 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | S - Sale | $12.33 | -7,266 | 32.3K | -18% | -$89.6K | |
| D | 2024-02-27 | 2024-02-26 | ENTA | Gardiner Nathaniel S. | CLO | M - OptEx | $8.99 | +5,187 | 75.7K | +7% | +$46.6K |
| 2024-02-14 | 2024-02-12 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | F - Tax | $12.41 | -973 | 39.6K | -2% | -$12.1K | |
| 2024-02-14 | 2024-02-12 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Off | A - Grant | $0.00 | +3,320 | 40.6K | +9% | $0 | |
| 2024-02-14 | 2024-02-12 | ENTA | Gardiner Nathaniel S. | CLO | F - Tax | $12.41 | -973 | 70.5K | -1% | -$12.1K | |
| 2024-02-14 | 2024-02-12 | ENTA | Gardiner Nathaniel S. | CLO | A - Grant | $0.00 | +3,320 | 71.5K | +5% | $0 | |
| 2024-02-14 | 2024-02-12 | ENTA | Luu Brendan | Chief Business Off | A - Grant | $0.00 | +3,320 | 40.1K | +9% | $0 | |
| 2024-02-14 | 2024-02-12 | ENTA | Luu Brendan | Chief Business Off | F - Tax | $12.41 | -973 | 39.1K | -2% | -$12.1K | |
| 2024-02-14 | 2024-02-12 | ENTA | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $12.41 | -755 | 28.3K | -3% | -$9,370 | |
| 2024-02-14 | 2024-02-12 | ENTA | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +2,576 | 29.0K | +10% | $0 | |
| 2024-02-14 | 2024-02-12 | ENTA | Or Yat Sun | CSO | A - Grant | $0.00 | +3,680 | 374.4K | +1.0% | $0 | |
| 2024-02-14 | 2024-02-12 | ENTA | Or Yat Sun | CSO | F - Tax | $12.41 | -1,080 | 373.3K | -0.3% | -$13.4K | |
| 2024-02-14 | 2024-02-12 | ENTA | MELLETT PAUL J | Chief Fin, Admin Off | F - Tax | $12.41 | -973 | 95.9K | -1% | -$12.1K | |
| 2024-02-14 | 2024-02-12 | ENTA | MELLETT PAUL J | Chief Fin, Admin Off | A - Grant | $0.00 | +3,320 | 96.9K | +4% | $0 | |
| 2024-02-14 | 2024-02-12 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $12.41 | -1,584 | 810.6K | -0.2% | -$19.7K | |
| 2024-02-14 | 2024-02-12 | ENTA | Luly Jay R. | Pres, CEO, Dir | A - Grant | $0.00 | +5,400 | 812.2K | +0.7% | $0 | |
| 2023-12-15 | 2023-12-13 | ENTA | Vance Terry | Dir | S - Sale | $9.12 | -15.3K | 5,800 | -73% | -$139.5K | |
| 2023-12-06 | 2023-12-05 | ENTA | Luly Jay R. | Pres, CEO, Dir | S - Sale | $9.63 | -7,230 | 806.8K | -0.9% | -$69.6K | |
| 2023-12-06 | 2023-12-05 | ENTA | Rottinghaus Scott T. | SVP, CMO | S - Sale | $9.63 | -534 | 26.5K | -2% | -$5,142 | |
| 2023-12-06 | 2023-12-05 | ENTA | Or Yat Sun | SVP, CSO, R, D | S - Sale | $9.63 | -2,412 | 370.7K | -0.6% | -$23.2K | |
| 2023-12-06 | 2023-12-05 | ENTA | MELLETT PAUL J | SVP, CFO, Fin, Admin | S - Sale | $9.63 | -2,412 | 93.5K | -3% | -$23.2K | |
| 2023-12-06 | 2023-12-05 | ENTA | Gardiner Nathaniel S. | SVP, GC | S - Sale | $9.63 | -2,412 | 68.2K | -3% | -$23.2K | |
| 2023-12-06 | 2023-12-05 | ENTA | Luu Brendan | SVP, Business Dev | S - Sale | $9.63 | -2,125 | 36.7K | -5% | -$20.5K | |
| 2023-12-06 | 2023-12-05 | ENTA | Kieffer Tara Lynn | SVP, New Prod. Strat, Dev | S - Sale | $9.63 | -2,125 | 37.3K | -5% | -$20.5K | |
| 2023-12-05 | 2023-12-01 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $9.49 | -5,787 | 814.0K | -0.7% | -$54.9K | |
| 2023-12-05 | 2023-12-01 | ENTA | Gardiner Nathaniel S. | SVP, GC | F - Tax | $9.49 | -1,595 | 70.6K | -2% | -$15.1K | |
| 2023-12-05 | 2023-12-01 | ENTA | MELLETT PAUL J | SVP, CFO, Fin, Admin | F - Tax | $9.49 | -1,595 | 96.0K | -2% | -$15.1K | |
| 2023-12-05 | 2023-12-01 | ENTA | Kieffer Tara Lynn | SVP, New Prod. Strat, Dev | F - Tax | $9.49 | -753 | 39.4K | -2% | -$7,146 | |
| 2023-12-05 | 2023-12-01 | ENTA | Luu Brendan | SVP, Business Dev | F - Tax | $9.49 | -753 | 38.9K | -2% | -$7,146 | |
| 2023-12-05 | 2023-12-01 | ENTA | Or Yat Sun | SVP, CSO, R, D | F - Tax | $9.49 | -1,595 | 373.1K | -0.4% | -$15.1K | |
| D | 2023-04-19 | 2023-04-18 | ENTA | Gardiner Nathaniel S. | SVP, GC | M - OptEx | $30.00 | +6,667 | 80.0K | +9% | +$200.0K |
| D | 2023-03-17 | 2023-03-16 | ENTA | Vance Terry | Dir | M - OptEx | $14.00 | +5,800 | 21.1K | +38% | +$81.2K |
| DM | 2023-03-17 | 2023-03-15 | ENTA | Or Yat Sun | SVP, CSO | S - Sale+OE | $44.45 | -13.9K | 388.4K | -3% | -$619.0K |
| D | 2023-03-17 | 2023-03-15 | ENTA | Or Yat Sun | SVP, CSO | M - OptEx | $14.00 | +13.9K | 388.6K | +4% | +$194.9K |
| DM | 2023-03-17 | 2023-03-15 | ENTA | MELLETT PAUL J | CFO, Treas | S - Sale+OE | $44.43 | -10.4K | 107.9K | -9% | -$463.8K |
| D | 2023-03-17 | 2023-03-15 | ENTA | MELLETT PAUL J | CFO, Treas | M - OptEx | $14.00 | +10.4K | 108.0K | +11% | +$146.2K |
| DM | 2023-03-14 | 2023-03-13 | ENTA | Luly Jay R. | Pres, CEO, Dir | S - Sale+OE | $45.16 | -27.9K | 837.0K | -3% | -$1.26M |
| D | 2023-03-14 | 2023-03-13 | ENTA | Luly Jay R. | Pres, CEO, Dir | M - OptEx | $14.00 | +27.9K | 847.7K | +3% | +$390.8K |
| MA | 2023-02-15 | 2023-02-13 | ENTA | Luly Jay R. | Pres, CEO, Dir | A - Grant | $0.00 | +52.1K | 840.4K | +7% | $0 |
| A | 2023-02-15 | 2023-02-13 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $52.77 | -20.6K | 819.8K | -2% | -$1.09M |
| M | 2023-02-15 | 2023-02-13 | ENTA | Luly Jay R. | Pres, CEO, Dir | A - Grant | $0.00 | +31.5K | 819.8K | +4% | $0 |
| 2023-02-15 | 2023-02-13 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $52.77 | -20.6K | 799.2K | -3% | -$1.09M |
Purchase Sale Sale after option exercise All abbreviations